Latest Resources

9 November 2018

Release of risky GM mosquitoes in Burkina Faso highly unethical

Press Release issued by African Centre for Biodiversity, Third World Network and GeneWatch UK Johannesburg, 9 November 2018 Release of risky GM mosquitoes in Burkina Faso highly unethical Risky genetically modified (GM) “male-sterile” mosquitoes are due to be released in the very near future, in Burkina Faso by the Target Malaria research consortium. However, Target […]

9 February 2018

Press Release: No benefit to imminent release of risky GM mosquitoes in Burkina Faso

Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release. The project is set to apply for a permit to make an open release of 10,000 GM Anopheles gambiae […]

8 February 2018

Briefing Paper: GM Mosquitoes in Burkina Faso

In this briefing paper ACB, TWN and GeneWatch UK discuss that genetically modified (GM) mosquitoes were exported from Imperial College in London to Burkina Faso in November 2016. They are currently in “contained use” facilities in Bobo-Dioulasso, and are being used in experiments by a research consortium called Target Malaria. However, these GM mosquitoes are […]

18 October 2017

Farm Input Subsidies and Civil Society’s Position in Mozambique

This statement represents the position of civil society in Mozambique on farm input subsidies.

16 October 2017

Civil society in Mozambique statement on farm input subsidies in that country

This statement represents the position of civil society in Mozambique on farm input subsidies in that country.

11 May 2006

Mozambique – GMO Legislation

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]